Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic
  • Search Hotels in Pleasanton

  • ROOMS:

Bragar Eagel & Squire, P.C. Is Investigating Wiley, and R1 RCM and Encourages Investors to Contact the Firm

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against John Wiley & Sons, Inc. (NYSE: WLY), and R1 RCM Corp. (NASDAQ: RCM). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

John Wiley & Sons, Inc. (NYSE: WLY)

On June 15, 2023, Wiley released its fourth quarter and fiscal year 2023 financial results, revealing that its fourth quarter revenue decreased 6%. The shortfall was due in part to the temporary suspension of Hindawi’s special issues publishing program after the Company identified as many as 1,700 articles with compromised and manipulated peer reviews and fabricated content.

On this news, Wiley’s stock price fell $4.17, or 11.4%, to close at $32.45 per share on June 15, 2023, thereby injuring investors.

Then, on October 10, 2023, Wiley announced that its CEO and President, Brian Napack, would be departing the Company, effective immediately. On this news, Wiley’s stock price fell $3.68, or 9.9%, to close at $30.95 per share on October 10, 2023, thereby injuring investors further.

For more information on the Wiley investigation go to:


On October 16, 2023, the market analyst and investment firm Jehoshaphat Research released a report on R1 RCM. Jehoshaphat stated in pertinent part, “[w]e are short RCM. We believe its financial accounting is so misrepresentative, its corporate governance so surprisingly bad, and the reflexivity of its business model so misunderstood that its stock is practically uninvestible today.”

On this news, the price of R1 RCM common stock declined by as much as 10% in intraday trading on October 16, 2023.

For more information on the R1 RCM investigation go to:

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648

Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Photography by Christophe Tomatis
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.